Mr. Nantiya Darakanon Chief Executive Officer Winnergy Medical Public Company Limited or WINMED Importers and distributors of machines and equipment for collection Analysis, diagnosis and medical treatment revealed that the company’s operating results for the 2nd quarter ended June 30, 2023 had a total income of 160.85 million baht and a net profit of 4.65 million baht, while the period The first 6 months of 2023 had a total income of 299.81 million baht and a net profit of 10.81 million baht.
The factors that support income are still at a good level. It comes from economic and social activities returning to normal after the epidemic situation of the COVID-19 virus has been resolved, resulting in the company’s existing product groups. tends to grow from the group of reproductive health care products of health checkups in hospitals that resulted in an increase in cervical cancer screening and receiving support from the project (NHSO) in screening for cervical cancer and increased revenues from the cell and molecular technology portfolio. due to increasing orders for laboratory reagents
As for the income structure by product group, there was a significant increase. Blood Banking and Blood Safety Products More use of operating room services The demand for blood and platelets of the hospital has been increasing continuously. In the 2nd quarter of 2023, the income was 88.28 million baht, an increase of 31.06 million baht or an increase of 54.28% compared to the same period last year with an income of 57.22 million baht.
The group of reproductive care products continued to grow. from having patients return to use the service in the hospital and recovery of health check-ups in hospitals It is also supported by the NHSO project. Causing the number of people to undergo cervical cancer screening to increase, in the second quarter of 2023, the income was 48.47 million baht, an increase of 4.77 million baht or an increase of 10.92% compared to the same period last year with an income of 43.70 million baht. Especially the cellular and molecular technology products that have done an excellent increase in performance.
This is because the research laboratories in the treatment of cancer patients of various medical student institutions. started the treatment project and can start the research process normally As a result, there is a continuous increase in the purchase of reagents. In the 2nd quarter of 2023, there was an income of 16.28 million baht, an increase of 6.25 million baht or an increase of 62.31% compared to the same period last year with an income of 10.03 million baht.
It can be seen that the original products of the company There is a clear growth trend after the COVID-19 has been resolved, making medical work education and research Started to order products and services of the company. The company continues to move forward with the growth of product groups, including plans to increase mobile blood donation units to 10 units for service in the year. 67 for the company’s operational plan in the year 66
At the same time, in addition to expanding investment, the company has adjusted its business strategy to generate more growth. from receiving support from the project (NHSO) in cervical cancer screening As a result, the number of people using cervical cancer screening services has increased many times. This will help support strong sales. Drive revenue this year to grow 30%, setting a new record. according to the plan
2023-08-15 05:35:23
#WINMED #confident #revenue #grow #receiving #NHSO #support #cervical #cancer #screening
